Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity
Forty patients with coronary heart disease (CHD) concurrent with hyperlipidemia were divided into 2 groups according to the baseline fibrinolytic activity. The group with the depressed fibrinolytic system displayed the highest atherogenicity index and levels of cholesterol, low and very low density lipoprotein cholesterol and half levels of high density lipoproteins. After 45-day ingestion of docanol, a new Russian food additive containing docosahexanoic and eicosapentaenoic acids there were positive changes in the lipid spectrum in the both groups. The fibrinolytic changes were heterodirectional: activator and plasma activities increased in the group of fibrinolytic depression while in the group of baseline normal fibrinolysis the activity of plasminogen activator fell.
Download PDF:
Citation:
Lyutova L.V., Karabasova M.A., Andreyenko G.V., Panchenko V.M., Isayev V.A., Sorokaletov S.M., Yershov A.A. (1996) Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity. Voprosy Meditsinskoi Khimii, 42(1), 64-70.
Lyutova L.V. et al. Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity // Voprosy Meditsinskoi Khimii. - 1996. - V. 42. -N 1. - P. 64-70.
Lyutova L.V. et al., "Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity." Voprosy Meditsinskoi Khimii 42.1 (1996): 64-70.
Lyutova, L. V., Karabasova, M. A., Andreyenko, G. V., Panchenko, V. M., Isayev, V. A., Sorokaletov, S. M., Yershov, A. A. (1996). Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients with coronary heart disease in relation to baseline fibrinolytic activity. Voprosy Meditsinskoi Khimii, 42(1), 64-70.
References
Андреенко Т.В., Лютова Л.В., Карабасова М.А. и др // Физиол журн. —1983. — № 3. —С. 38-44. Scholar google search
Верткин А.Л., Мартынов И.В., Васягин А.И. // Кардиология. — 1993. — № 4. — С. 13-16. Scholar google search
Влияние эйконола на состав крови и рекомендации по его применению // Под ред. А.Л. Вершина. — М , 1993. Scholar google search
Карабасова М.А., Исаев В.А., Панченко В.М. и др. // Вестн. Моск. ун-та. — L995. — Сер. Биология — № 4 — С. 3-7. Scholar google search
Лютова Л.В., Андреенко Т.В., Карабасова М.А. и др // Вопр. мед. химии. — 1989. — № 4- С. 75-78. Scholar google search
Методы исследования фибринолитической системы крови // Под ред. Г.В.Андреенко - М. 1981. Scholar google search
Панченко Е.П., Лютова Л.В., Карасев А.В. и др. // Кардиология — 1988. — № 5. — С. 64-69. Scholar google search
Панченко В.М, Ершов А.А., Сороколетов С.М. и др. // Вестн. Моск. ун-та. — 1995 — Сер. Биология. — № 3. — С 40-46. Scholar google search
Пыж M.B., Грацианский Н.А., Арешев Г.П., Кулакова С.И. //Кардиология. — 1993. — № 5 - С 21-26. Scholar google search
Репин В.С. // Успехи соврем. биол. — 1990 - Т. 109, № 1. — С 120-129. Scholar google search
